Drug-induced QT prolongation and torsades de pointes: Evaluation of a QT nomogram

QJM: An International Journal of Medicine

Volumn 100, Issue 10, 2007, Pages 609-615

  Chan, A ^a   Isbister, Geoffrey K ^a,b,d   Kirkpatrick, C M J ^a   Dufful, S B ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d NEWCASTLE MATER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMIODARONE; AMISULPRIDE; ARSENIC; ASTEMIZOLE; BEPRIDIL; CESIUM; CIPROFLOXACIN; CITALOPRAM; COCAINE; DIGOXIN; DOXEPIN; ENALAPRIL; ERYTHROMYCIN; FLECAINIDE; FLUCONAZOLE; FLUOXETINE; HALOPERIDOL; METHADONE; PARATHION; PENTAMIDINE; PIMOZIDE; PIPAMPERONE; QUINIDINE; SOTALOL; TERFENADINE; TERODILINE; THIORIDAZINE; UNINDEXED DRUG; VORICONAZOLE;

ACCURACY; ARTICLE; DRUG OVERDOSE; ELECTROCARDIOGRAPHY; HEART RATE; HUMAN; NOMOGRAM; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RISK ASSESSMENT; RR INTERVAL; SENSITIVITY AND SPECIFICITY; TORSADE DES POINTES;

EID: 35148890709     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcm072     Document Type: Article

References (20)

1. Kannankeril PJ, Roden DM. Drug-induced long QT and torsade de pointes: recent advances. Curr Opin Cardiol 2007; 22:39-43.
2. Malik M, Camm AJ. Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling. Drug Saf 2001; 24 323-51.
3. Malik M, Farbom P, Batchvarov V, Hnatkova K, Camm AJ. Relation between QT and RRr intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval. Heart 2002; 87:220-8.
4. Batchvarov VN, Ghuran A, Smetana P, Hnatkova K, Harries M, Dilaveris P, Camm AJ, Malik M. QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability. Am J Physiol Heart Circ Physiol 2002; 282:H2356-63.
5. Piotrovsky V. Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation. AAPS J 2005; 7:E609-24.
6. Couderc JP, Xiaojuan X, Zareba W, Moss AJ. Assessment of the stability of the individual-based correction of QT interval for heart rate. Ann Noninvasive Electrocardiol 2005; 10:25-34.
7. Fossa AA, Wisialowski T, Magnano A, Wolfgang E, Winslow R, Gorczyca W, Crimin K, Raunig DL. Dynamic beat-to-beat modeling of the QT-RR interval relationship: Analysis of QT prolongation during alterations of autonomic state versus human ether a-go-go-related gene inhibition. J Pharmacol Exp Ther 2005; 312:1-11.
8. Friberg LE, Isbister GK, Duffull SB. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. Br J Clin Pharmacol 2006; 61:177-90.
9. Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004; 42:277-85.
10. Isbister GK, Friberg LE, Duffull SB. Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose. Intensive Care Med 2006; 32:1060-5.
11. Fermini B, Fossa AA. The impact of drug-induced QT interval prolongation on drug discovery and development. Nat Rev Drug Discov 2003; 2 439-47.
12. Daly LE, Bourke GJ. Interpretation and uses of medical statistics. Blackwell Science, 2000.
13. Stratmann HG, Kennedy HL. Torsades de pointes associated with drugs and toxins: Recognition and management. Am Heart J 1987; 113 1470-82.
14. Desai M, Li L, Desta Z, Malik M, Flockhart D. Variability of heart rate correction methods for the QT interval. Br J Clin Pharmacol 2003; 55:511-17.
15. Luo S, Michler K, Johnston P, Macfarlane PW. A comparison of commonly used QT correction formulae: The effect of heart rate on the QTc of normal ECGs. J Electrocardiol 2004; 37 (Suppl.): 81-90.
16. Balit CR, Isbister GK, Hackett LP, Whyte IM. Quetiapine poisoning: A case series. Ann Emerg Med 2003; 42:751-8.
17. Isbister GK, Balit CR. Bupropion Overdose: QTc Prolongation and Its Clinical Significance. Ann Pharmacother 2003; 37:999-1002.
18. Gil M, Sala M, Anguera I, Chapinal O, Cervantes M, Guma JR, Segura F. QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone. Am J Cardiol 2003; 92:995-7.
19. Unnikrishnan D, Dutcher JP, Varshneya N, Lucariello R, Api M, Garl S, Wiernik PH, Chiaramida S. Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide. Blood 2001; 97 1514-16.
20. Voigt L, Coromilas J, Saul BI, Kassotis J. Amiodarone-induced torsade de pointes during bladder irrigation: An unusual presentation-a case report. Angiology 2003; 54:229-31.